The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire
Teva's Trial Results finds drug could slow Huntington's disease - Jewish Business News
Is TEVA a Pain Before the Gain? – PGM Capital
Teva cuts forecast for 2017 amid competition to flagship Copaxone drug | The Times of Israel
Teva Reports Second Quarter 2021 Financial Results
Teva's new CEO Schultz to take post Wednesday | The Times of Israel
TEVA Pre Worlds Netherlands – head to head results
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Reports Third Quarter 2016 Results - Pharmaceutical Processing World
Teva Pharmaceutical Industries Ltd. - Yesterday we shared Teva's Q1 2020 financial results. View the highlights of our contributions to #COVID19 efforts worldwide, focusing on employee safety and ensuring that quality medicines
Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia - Pharmaceutical Business review
Teva Reports Second Quarter 2021 Financial Results | Business Wire
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Industries Ltd. Fourth Quarter 2019 Results 2020-02-12¢ described in slide 29-30 - [PDF Document]
Teva Reports Second Quarter 2020 Financial Results | Business Wire
Teva Gets Actavis Boost, Q4 Results Top Estimates
Teva | INDEFF
Teva Reports Third Quarter 2021 Financial Results | Business Wire
Teva announces positive top-line results from AJOVY clinical trials in Japan - Pharmaceutical Business review